ID   RPE65_HUMAN             Reviewed;         533 AA.
AC   Q16518; A8K1L0; Q5T9U3;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Retinoid isomerohydrolase;
DE            EC=3.1.1.64;
DE   AltName: Full=All-trans-retinyl-palmitate hydrolase;
DE   AltName: Full=Retinal pigment epithelium-specific 65 kDa protein;
DE   AltName: Full=Retinol isomerase;
GN   Name=RPE65;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Retinal pigment epithelium;
RX   PubMed=7633413; DOI=10.1093/hmg/4.4.641;
RA   Nicoletti A., Wong D.J., Kawase K., Gibson L.H., Yang-Feng T.L.,
RA   Richards J.E., Thompson D.A.;
RT   "Molecular characterization of the human gene encoding an abundant 61
RT   kDa protein specific to the retinal pigment epithelium.";
RL   Hum. Mol. Genet. 4:641-649(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS RP20 TRP-91; LYS-102;
RP   THR-132; SER-341; GLY-452 AND ASP-473.
RX   PubMed=9501220; DOI=10.1073/pnas.95.6.3088;
RA   Morimura H., Fishman G.A., Grover S.A., Fulton A.B., Berson E.L.,
RA   Dryja T.P.;
RT   "Mutations in the RPE65 gene in patients with autosomal recessive
RT   retinitis pigmentosa or Leber congenital amaurosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3088-3093(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 98-118, PHOSPHORYLATION AT THR-101; THR-105 AND
RP   SER-117, PALMITOYLATION AT CYS-112, MUTAGENESIS OF CYS-106 AND
RP   CYS-112, ACETYLATION AT LYS-113, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19049981; DOI=10.1074/jbc.M807248200;
RA   Takahashi Y., Moiseyev G., Ablonczy Z., Chen Y., Crouch R.K., Ma J.X.;
RT   "Identification of a novel palmitylation site essential for membrane
RT   association and isomerohydrolase activity of RPE65.";
RL   J. Biol. Chem. 284:3211-3218(2009).
RN   [8]
RP   MUTAGENESIS OF HIS-180; HIS-241; HIS-313; GLU-469 AND HIS-527.
RX   PubMed=16198348; DOI=10.1016/j.febslet.2005.09.002;
RA   Takahashi Y., Moiseyev G., Chen Y., Ma J.X.;
RT   "Identification of conserved histidines and glutamic acid as key
RT   residues for isomerohydrolase activity of RPE65, an enzyme of the
RT   visual cycle in the retinal pigment epithelium.";
RL   FEBS Lett. 579:5414-5418(2005).
RN   [9]
RP   FUNCTION.
RX   PubMed=16116091; DOI=10.1073/pnas.0503460102;
RA   Moiseyev G., Chen Y., Takahashi Y., Wu B.X., Ma J.X.;
RT   "RPE65 is the isomerohydrolase in the retinoid visual cycle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12413-12418(2005).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH MYO7A.
RX   PubMed=21493626; DOI=10.1093/hmg/ddr155;
RA   Lopes V.S., Gibbs D., Libby R.T., Aleman T.S., Welch D.L., Lillo C.,
RA   Jacobson S.G., Radu R.A., Steel K.P., Williams D.S.;
RT   "The Usher 1B protein, MYO7A, is required for normal localization and
RT   function of the visual retinoid cycle enzyme, RPE65.";
RL   Hum. Mol. Genet. 20:2560-2570(2011).
RN   [11]
RP   VARIANT LCA2 THR-363.
RX   PubMed=9326941; DOI=10.1038/ng1097-194;
RA   Gu S.M., Thompson D.A., Srikumari C.R., Lorenz B., Finckh U.,
RA   Nicoletti A., Murthy K.R., Rathmann M., Kumaramanickavel G.,
RA   Denton M.J., Gal A.;
RT   "Mutations in RPE65 cause autosomal recessive childhood-onset severe
RT   retinal dystrophy.";
RL   Nat. Genet. 17:194-197(1997).
RN   [12]
RP   VARIANTS LCA2 PRO-22 AND TYR-68.
RX   PubMed=9801879; DOI=10.1038/sj.ejhg.5200205;
RA   Marlhens F., Griffoin J.-M., Bareil C., Arnaud B., Claustres M.,
RA   Hamel C.P.;
RT   "Autosomal recessive retinal dystrophy associated with two novel
RT   mutations in the RPE65 gene.";
RL   Eur. J. Hum. Genet. 6:527-531(1998).
RN   [13]
RP   VARIANTS LCA2 TYR-330; THR-363 AND VAL-434.
RX   PubMed=10090910; DOI=10.1086/302335;
RA   Perrault I., Rozet J.-M., Ghazi I., Leowski C., Bonnemaison M.,
RA   Gerber S., Ducroq D., Cabot A., Souied E., Dufier J.-L., Munnich A.,
RA   Kaplan J.;
RT   "Different functional outcome of RetGC1 and RPE65 gene mutations in
RT   Leber congenital amaurosis.";
RL   Am. J. Hum. Genet. 64:1225-1228(1999).
RN   [14]
RP   VARIANTS LCA2 PHE-287 AND GLY-393, AND VARIANT LYS-321.
RX   PubMed=10766140; DOI=10.1001/archopht.118.4.538;
RA   Lotery A.J., Namperumalsamy P., Jacobson S.G., Weleber R.G.,
RA   Fishman G.A., Musarella M.A., Hoyt C.S., Heon E., Levin A., Jan J.,
RA   Lam B., Carr R.E., Franklin A., Radha S., Andorf J.L., Sheffield V.C.,
RA   Stone E.M.;
RT   "Mutation analysis of 3 genes in patients with Leber congenital
RT   amaurosis.";
RL   Arch. Ophthalmol. 118:538-543(2000).
RN   [15]
RP   VARIANTS RP20 HIS-79; HIS-85; TRP-91; GLN-95; THR-132; TYR-167;
RP   THR-294; VAL-436 AND VAL-528.
RX   PubMed=11095629;
RA   Thompson D.A., Gyuerues P., Fleischer L.L., Bingham E.L.,
RA   McHenry C.L., Apfelstedt-Sylla E., Zrenner E., Lorenz B.,
RA   Richards J.E., Jacobson S.G., Sieving P.A., Gal A.;
RT   "Genetics and phenotypes of RPE65 mutations in inherited retinal
RT   degeneration.";
RL   Invest. Ophthalmol. Vis. Sci. 41:4293-4299(2000).
RN   [16]
RP   VARIANTS LCA2 SER-40; GLN-44; GLN-91; ASP-144; TYR-182 AND GLN-417,
RP   AND VARIANT LYS-321.
RX   PubMed=11462243; DOI=10.1002/humu.1168;
RA   Simovich M.J., Miller B., Ezzeldin H., Kirkland B.T., McLeod G.,
RA   Fulmer C., Nathans J., Jacobson S.G., Pittler S.J.;
RT   "Four novel mutations in the RPE65 gene in patients with Leber
RT   congenital amaurosis.";
RL   Hum. Mutat. 18:164-164(2001).
RN   [17]
RP   VARIANT RP20 HIS-368.
RX   PubMed=12960219; DOI=10.1136/jmg.40.9.709;
RA   Yzer S., van den Born L.I., Schuil J., Kroes H.Y., van Genderen M.M.,
RA   Boonstra F.N., van den Helm B., Brunner H.G., Koenekoop R.K.,
RA   Cremers F.P.;
RT   "A Tyr368His RPE65 founder mutation is associated with variable
RT   expression and progression of early onset retinal dystrophy in 10
RT   families of a genetically isolated population.";
RL   J. Med. Genet. 40:709-713(2003).
RN   [18]
RP   VARIANTS LCA2 36-LEU--LEU-38 DEL AND CYS-435.
RX   PubMed=14611946; DOI=10.1016/j.visres.2003.08.008;
RA   Sitorus R.S., Lorenz B., Preising M.N.;
RT   "Analysis of three genes in Leber congenital amaurosis in Indonesian
RT   patients.";
RL   Vision Res. 43:3087-3093(2003).
RN   [19]
RP   VARIANT LCA2 CYS-431.
RX   PubMed=14962443; DOI=10.1016/S0002-9394(03)00913-9;
RA   Al-Khayer K., Hagstrom S., Pauer G., Zegarra H., Sears J.,
RA   Traboulsi E.I.;
RT   "Thirty-year follow-up of a patient with Leber congenital amaurosis
RT   and novel RPE65 mutations.";
RL   Am. J. Ophthalmol. 137:375-377(2004).
RN   [20]
RP   VARIANTS LCA2 GLN-44; ASP-148; ASN-182; TYR-330; THR-363; VAL-434 AND
RP   ASP-473.
RX   PubMed=15024725; DOI=10.1002/humu.20010;
RA   Hanein S., Perrault I., Gerber S., Tanguy G., Barbet F., Ducroq D.,
RA   Calvas P., Dollfus H., Hamel C., Lopponen T., Munier F., Santos L.,
RA   Shalev S., Zafeiriou D., Dufier J.-L., Munnich A., Rozet J.-M.,
RA   Kaplan J.;
RT   "Leber congenital amaurosis: comprehensive survey of the genetic
RT   heterogeneity, refinement of the clinical definition, and genotype-
RT   phenotype correlations as a strategy for molecular diagnosis.";
RL   Hum. Mutat. 23:306-317(2004).
RN   [21]
RP   VARIANT RP20 TRP-515.
RX   PubMed=15557452; DOI=10.1167/iovs.04-0544;
RA   Kondo H., Qin M., Mizota A., Kondo M., Hayashi H., Hayashi K.,
RA   Oshima K., Tahira T., Hayashi K.;
RT   "A homozygosity-based search for mutations in patients with autosomal
RT   recessive retinitis pigmentosa, using microsatellite markers.";
RL   Invest. Ophthalmol. Vis. Sci. 45:4433-4439(2004).
RN   [22]
RP   VARIANTS LCA2 SER-40; TRP-91; TYR-182; ASP-239; GLU-393 AND ASP-473.
RX   PubMed=16205573; DOI=10.1097/00006982-200510000-00016;
RA   Galvin J.A., Fishman G.A., Stone E.M., Koenekoop R.K.;
RT   "Evaluation of genotype-phenotype associations in Leber congenital
RT   amaurosis.";
RL   Retina 25:919-929(2005).
RN   [23]
RP   VARIANT LCA2 LEU-470.
RX   PubMed=17297704;
RA   Gandra M., Sundaramurthy S., Kumaramanickavel G.;
RT   "Gene symbol: RPE65. Disease: Leber's congenital amaurosis. Accession
RT   #Hm0548.";
RL   Hum. Genet. 118:780-780(2006).
RN   [24]
RP   VARIANTS LCA2 PRO-22; VAL-70; PRO-91; LYS-102; ASP-144; TYR-167 AND
RP   ARG-313.
RX   PubMed=17724218; DOI=10.1167/iovs.07-0068;
RA   Simonelli F., Ziviello C., Testa F., Rossi S., Fazzi E., Bianchi P.E.,
RA   Fossarello M., Signorini S., Bertone C., Galantuomo S., Brancati F.,
RA   Valente E.M., Ciccodicola A., Rinaldi E., Auricchio A., Banfi S.;
RT   "Clinical and molecular genetics of Leber's congenital amaurosis: a
RT   multicenter study of Italian patients.";
RL   Invest. Ophthalmol. Vis. Sci. 48:4284-4290(2007).
RN   [25]
RP   VARIANT LCA2 TRP-91.
RX   PubMed=18682808;
RA   Seong M.W., Kim S.Y., Yu Y.S., Hwang J.M., Kim J.Y., Park S.S.;
RT   "Molecular characterization of Leber congenital amaurosis in
RT   Koreans.";
RL   Mol. Vis. 14:1429-1436(2008).
RN   [26]
RP   VARIANT GLY-477, AND ROLE IN AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA
RP   WITH CHOROIDAL INVOLVEMENT.
RX   PubMed=21654732; DOI=10.1038/ejhg.2011.86;
RA   Bowne S.J., Humphries M.M., Sullivan L.S., Kenna P.F., Tam L.C.,
RA   Kiang A.S., Campbell M., Weinstock G.M., Koboldt D.C., Ding L.,
RA   Fulton R.S., Sodergren E.J., Allman D., Millington-Ward S., Palfi A.,
RA   McKee A., Blanton S.H., Slifer S., Konidari I., Farrar G.J.,
RA   Daiger S.P., Humphries P.;
RT   "A dominant mutation in RPE65 identified by whole-exome sequencing
RT   causes retinitis pigmentosa with choroidal involvement.";
RL   Eur. J. Hum. Genet. 19:1074-1081(2011).
RN   [27]
RP   VARIANTS ILE-99 AND ARG-333.
RX   PubMed=21602930; DOI=10.1371/journal.pone.0019458;
RA   Li L., Xiao X., Li S., Jia X., Wang P., Guo X., Jiao X., Zhang Q.,
RA   Hejtmancik J.F.;
RT   "Detection of variants in 15 genes in 87 unrelated Chinese patients
RT   with Leber congenital amaurosis.";
RL   PLoS ONE 6:E19458-E19458(2011).
RN   [28]
RP   VARIANTS RP20 VAL-70; TRP-91; ASP-239 AND HIS-368.
RX   PubMed=22334370; DOI=10.1002/humu.22045;
RA   Neveling K., Collin R.W., Gilissen C., van Huet R.A., Visser L.,
RA   Kwint M.P., Gijsen S.J., Zonneveld M.N., Wieskamp N., de Ligt J.,
RA   Siemiatkowska A.M., Hoefsloot L.H., Buckley M.F., Kellner U.,
RA   Branham K.E., den Hollander A.I., Hoischen A., Hoyng C.,
RA   Klevering B.J., van den Born L.I., Veltman J.A., Cremers F.P.,
RA   Scheffer H.;
RT   "Next-generation genetic testing for retinitis pigmentosa.";
RL   Hum. Mutat. 33:963-972(2012).
RN   [29]
RP   VARIANTS ARG-67 AND CYS-368.
RX   PubMed=22509104;
RA   Xu F., Dong Q., Liu L., Li H., Liang X., Jiang R., Sui R., Dong F.;
RT   "Novel RPE65 mutations associated with Leber congenital amaurosis in
RT   Chinese patients.";
RL   Mol. Vis. 18:744-750(2012).
RN   [30]
RP   VARIANT RP20 PRO-60.
RX   PubMed=23878505;
RA   Kabir F., Naz S., Riazuddin S.A., Naeem M.A., Khan S.N., Husnain T.,
RA   Akram J., Sieving P.A., Hejtmancik J.F., Riazuddin S.;
RT   "Novel mutations in RPE65 identified in consanguineous Pakistani
RT   families with retinal dystrophy.";
RL   Mol. Vis. 19:1554-1564(2013).
RN   [31]
RP   VARIANT LYS-321.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Plays important roles in the production of 11-cis
CC       retinal and in visual pigment regeneration. The soluble form binds
CC       vitamin A (all-trans-retinol), making it available for LRAT
CC       processing to all-trans-retinyl ester. The membrane form,
CC       palmitoylated by LRAT, binds all-trans-retinyl esters, making them
CC       available for IMH (isomerohydrolase) processing to all-cis-
CC       retinol. The soluble form is regenerated by transferring its
CC       palmitoyl groups onto 11-cis-retinol, a reaction catalyzed by
CC       LRAT. The enzymatic activity is linearly dependent of the
CC       expression levels and membrane association.
CC       {ECO:0000269|PubMed:16116091, ECO:0000269|PubMed:21654732}.
CC   -!- CATALYTIC ACTIVITY: An all-trans-retinyl ester + H(2)O = 11-cis-
CC       retinol + a fatty acid.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with MYO7A; this mediates light-dependent
CC       intracellular transport of RPE65. {ECO:0000269|PubMed:21493626}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Lipid-anchor {ECO:0000250}. Microsome membrane
CC       {ECO:0000250}. Note=Attached to the membrane by a lipid anchor
CC       when palmitoylated (membrane form), soluble when unpalmitoylated
CC       (By similarity). Undergoes light-dependent intracellular transport
CC       to become more concentrated in the central region of the retina
CC       pigment epithelium cells. {ECO:0000250,
CC       ECO:0000269|PubMed:21493626}.
CC   -!- TISSUE SPECIFICITY: Retinal pigment epithelium specific.
CC       {ECO:0000269|PubMed:21493626}.
CC   -!- PTM: Palmitoylation by LRAT regulates ligand binding specificity;
CC       the palmitoylated form (membrane form) specifically binds all-
CC       trans-retinyl-palmitate, while the soluble unpalmitoylated form
CC       binds all-trans-retinol (vitamin A). {ECO:0000250}.
CC   -!- DISEASE: Leber congenital amaurosis 2 (LCA2) [MIM:204100]: A
CC       severe dystrophy of the retina, typically becoming evident in the
CC       first years of life. Visual function is usually poor and often
CC       accompanied by nystagmus, sluggish or near-absent pupillary
CC       responses, photophobia, high hyperopia and keratoconus.
CC       {ECO:0000269|PubMed:10090910, ECO:0000269|PubMed:10766140,
CC       ECO:0000269|PubMed:11462243, ECO:0000269|PubMed:14611946,
CC       ECO:0000269|PubMed:14962443, ECO:0000269|PubMed:15024725,
CC       ECO:0000269|PubMed:16205573, ECO:0000269|PubMed:17297704,
CC       ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:18682808,
CC       ECO:0000269|PubMed:9326941, ECO:0000269|PubMed:9801879}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Retinitis pigmentosa 20 (RP20) [MIM:613794]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:11095629,
CC       ECO:0000269|PubMed:12960219, ECO:0000269|PubMed:15557452,
CC       ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:23878505,
CC       ECO:0000269|PubMed:9501220}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in RPE65 are a cause of autosomal dominant
CC       retinitis pigmentosa with choroidal involvement (PubMed:21654732).
CC       Affected individuals show reduction of central vision,
CC       constriction of visual fields, night blindness and chorioretinal
CC       atrophy. {ECO:0000269|PubMed:21654732}.
CC   -!- SIMILARITY: Belongs to the carotenoid oxygenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the RPE65 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/rpe65mut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18991; AAA99012.1; -; mRNA.
DR   EMBL; U20510; AAC14586.1; -; Genomic_DNA.
DR   EMBL; U20476; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20477; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20478; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20479; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20481; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20482; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20484; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20485; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; U20486; AAC14586.1; JOINED; Genomic_DNA.
DR   EMBL; AF039868; AAC39660.1; -; Genomic_DNA.
DR   EMBL; AF039855; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039856; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039857; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039858; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039859; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039860; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039861; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039862; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039863; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039864; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039865; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039866; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AF039867; AAC39660.1; JOINED; Genomic_DNA.
DR   EMBL; AK289925; BAF82614.1; -; mRNA.
DR   EMBL; AL139413; CAI18957.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06478.1; -; Genomic_DNA.
DR   EMBL; BC075035; AAH75035.1; -; mRNA.
DR   EMBL; BC075036; AAH75036.1; -; mRNA.
DR   CCDS; CCDS643.1; -.
DR   RefSeq; NP_000320.1; NM_000329.2.
DR   UniGene; Hs.2133; -.
DR   ProteinModelPortal; Q16518; -.
DR   SMR; Q16518; -.
DR   BioGrid; 112041; 6.
DR   IntAct; Q16518; 1.
DR   STRING; 9606.ENSP00000262340; -.
DR   SwissLipids; SLP:000000687; -.
DR   iPTMnet; Q16518; -.
DR   PhosphoSitePlus; Q16518; -.
DR   SwissPalm; Q16518; -.
DR   BioMuta; RPE65; -.
DR   DMDM; 44888872; -.
DR   PaxDb; Q16518; -.
DR   PeptideAtlas; Q16518; -.
DR   PRIDE; Q16518; -.
DR   Ensembl; ENST00000262340; ENSP00000262340; ENSG00000116745.
DR   GeneID; 6121; -.
DR   KEGG; hsa:6121; -.
DR   UCSC; uc001dei.2; human.
DR   CTD; 6121; -.
DR   DisGeNET; 6121; -.
DR   GeneCards; RPE65; -.
DR   GeneReviews; RPE65; -.
DR   HGNC; HGNC:10294; RPE65.
DR   MalaCards; RPE65; -.
DR   MIM; 180069; gene.
DR   MIM; 204100; phenotype.
DR   MIM; 613794; phenotype.
DR   neXtProt; NX_Q16518; -.
DR   OpenTargets; ENSG00000116745; -.
DR   Orphanet; 180; Choroideremia.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   Orphanet; 364055; Severe early-childhood-onset retinal dystrophy.
DR   PharmGKB; PA34655; -.
DR   eggNOG; KOG1285; Eukaryota.
DR   eggNOG; COG3670; LUCA.
DR   GeneTree; ENSGT00500000044783; -.
DR   HOGENOM; HOG000232156; -.
DR   HOVERGEN; HBG050679; -.
DR   InParanoid; Q16518; -.
DR   KO; K11158; -.
DR   OMA; HFVPDRK; -.
DR   OrthoDB; EOG091G04WW; -.
DR   PhylomeDB; Q16518; -.
DR   TreeFam; TF314019; -.
DR   BioCyc; MetaCyc:ENSG00000116745-MONOMER; -.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   ChiTaRS; RPE65; human.
DR   GeneWiki; RPE65; -.
DR   GenomeRNAi; 6121; -.
DR   PRO; PR:Q16518; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116745; -.
DR   CleanEx; HS_RPE65; -.
DR   Genevisible; Q16518; HS.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISS:AgBase.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0052885; F:all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity; ISS:AgBase.
DR   GO; GO:0052884; F:all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity; TAS:Reactome.
DR   GO; GO:1901612; F:cardiolipin binding; ISS:AgBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IEA:InterPro.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISS:AgBase.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISS:AgBase.
DR   GO; GO:0004744; F:retinal isomerase activity; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0003407; P:neural retina development; IEA:Ensembl.
DR   GO; GO:0007468; P:regulation of rhodopsin gene expression; IEA:Ensembl.
DR   GO; GO:0001895; P:retina homeostasis; IMP:UniProtKB.
DR   GO; GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0042574; P:retinal metabolic process; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   GO; GO:0006776; P:vitamin A metabolic process; TAS:ProtInc.
DR   InterPro; IPR004294; Carotenoid_Oase.
DR   PANTHER; PTHR10543; PTHR10543; 1.
DR   Pfam; PF03055; RPE65; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Endoplasmic reticulum;
KW   Hydrolase; Iron; Isomerase; Leber congenital amaurosis; Lipoprotein;
KW   Membrane; Metal-binding; Microsome; Palmitate; Phosphoprotein;
KW   Polymorphism; Reference proteome; Retinitis pigmentosa;
KW   Sensory transduction; Vision.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q28175}.
FT   CHAIN         2    533       Retinoid isomerohydrolase.
FT                                /FTId=PRO_0000143943.
FT   METAL       180    180       Iron; catalytic. {ECO:0000250}.
FT   METAL       241    241       Iron; catalytic. {ECO:0000250}.
FT   METAL       313    313       Iron; catalytic. {ECO:0000250}.
FT   METAL       527    527       Iron; catalytic. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:Q28175}.
FT   MOD_RES     101    101       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19049981}.
FT   MOD_RES     105    105       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19049981}.
FT   MOD_RES     113    113       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19049981}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000269|PubMed:19049981}.
FT   LIPID       112    112       S-palmitoyl cysteine; in membrane form.
FT                                {ECO:0000269|PubMed:19049981}.
FT   LIPID       231    231       S-palmitoyl cysteine; in membrane form.
FT                                {ECO:0000250}.
FT   LIPID       329    329       S-palmitoyl cysteine; in membrane form.
FT                                {ECO:0000250}.
FT   LIPID       330    330       S-palmitoyl cysteine; in membrane form.
FT                                {ECO:0000250}.
FT   VARIANT      22     22       L -> P (in LCA2; dbSNP:rs61751277).
FT                                {ECO:0000269|PubMed:17724218,
FT                                ECO:0000269|PubMed:9801879}.
FT                                /FTId=VAR_017126.
FT   VARIANT      36     38       Missing (in LCA2).
FT                                {ECO:0000269|PubMed:14611946}.
FT                                /FTId=VAR_060808.
FT   VARIANT      40     40       G -> S (in LCA2; dbSNP:rs61751281).
FT                                {ECO:0000269|PubMed:11462243,
FT                                ECO:0000269|PubMed:16205573}.
FT                                /FTId=VAR_017127.
FT   VARIANT      44     44       R -> Q (in LCA2; dbSNP:rs61751282).
FT                                {ECO:0000269|PubMed:11462243,
FT                                ECO:0000269|PubMed:15024725}.
FT                                /FTId=VAR_017128.
FT   VARIANT      60     60       L -> P (in RP20).
FT                                {ECO:0000269|PubMed:23878505}.
FT                                /FTId=VAR_071672.
FT   VARIANT      67     67       L -> R (found in a patient with
FT                                relatively mild LCA2; uncertain
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:22509104}.
FT                                /FTId=VAR_070172.
FT   VARIANT      68     68       H -> Y (in LCA2; dbSNP:rs61752866).
FT                                {ECO:0000269|PubMed:9801879}.
FT                                /FTId=VAR_017129.
FT   VARIANT      70     70       F -> V (in LCA2 and RP20).
FT                                {ECO:0000269|PubMed:17724218,
FT                                ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_067160.
FT   VARIANT      79     79       Y -> H (in RP20; dbSNP:rs61752869).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060809.
FT   VARIANT      85     85       R -> H (in RP20; uncertain pathological
FT                                significance; dbSNP:rs61752870).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060810.
FT   VARIANT      91     91       R -> P (in LCA2; dbSNP:rs61752873).
FT                                {ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_067161.
FT   VARIANT      91     91       R -> Q (in LCA2; dbSNP:rs61752873).
FT                                {ECO:0000269|PubMed:11462243}.
FT                                /FTId=VAR_017131.
FT   VARIANT      91     91       R -> W (in RP20; dbSNP:rs61752871).
FT                                {ECO:0000269|PubMed:11095629,
FT                                ECO:0000269|PubMed:16205573,
FT                                ECO:0000269|PubMed:18682808,
FT                                ECO:0000269|PubMed:22334370,
FT                                ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_017130.
FT   VARIANT      95     95       E -> Q (in RP20; dbSNP:rs61752874).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060811.
FT   VARIANT      99     99       V -> I (found in a patient with LCA2;
FT                                uncertain pathological significance;
FT                                dbSNP:rs143056561).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067162.
FT   VARIANT     102    102       E -> K (in RP20 and LCA2;
FT                                dbSNP:rs62642584).
FT                                {ECO:0000269|PubMed:17724218,
FT                                ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_060812.
FT   VARIANT     132    132       A -> T (in RP20; unknown pathological
FT                                significance; dbSNP:rs61752878).
FT                                {ECO:0000269|PubMed:11095629,
FT                                ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_017132.
FT   VARIANT     144    144       Y -> D (in LCA2; dbSNP:rs61752880).
FT                                {ECO:0000269|PubMed:11462243,
FT                                ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_017133.
FT   VARIANT     148    148       E -> D (in LCA2; dbSNP:rs61752882).
FT                                {ECO:0000269|PubMed:15024725}.
FT                                /FTId=VAR_060813.
FT   VARIANT     167    167       D -> Y (in RP20 and LCA2;
FT                                dbSNP:rs61752883).
FT                                {ECO:0000269|PubMed:11095629,
FT                                ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_060814.
FT   VARIANT     182    182       H -> N (in LCA2; dbSNP:rs61752884).
FT                                {ECO:0000269|PubMed:15024725}.
FT                                /FTId=VAR_060815.
FT   VARIANT     182    182       H -> Y (in LCA2; dbSNP:rs61752884).
FT                                {ECO:0000269|PubMed:11462243,
FT                                ECO:0000269|PubMed:16205573}.
FT                                /FTId=VAR_017134.
FT   VARIANT     239    239       Y -> D (in LCA2 and RP20;
FT                                dbSNP:rs61752896).
FT                                {ECO:0000269|PubMed:16205573,
FT                                ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_060816.
FT   VARIANT     287    287       V -> F (in LCA2; dbSNP:rs281865289).
FT                                {ECO:0000269|PubMed:10766140}.
FT                                /FTId=VAR_017135.
FT   VARIANT     294    294       K -> T (in RP20; dbSNP:rs61752901).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060817.
FT   VARIANT     313    313       H -> R (in LCA2).
FT                                {ECO:0000269|PubMed:17724218}.
FT                                /FTId=VAR_067163.
FT   VARIANT     321    321       N -> K (in dbSNP:rs149916178).
FT                                {ECO:0000269|PubMed:10766140,
FT                                ECO:0000269|PubMed:11462243,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_017136.
FT   VARIANT     330    330       C -> Y (in LCA2; dbSNP:rs61752908).
FT                                {ECO:0000269|PubMed:10090910,
FT                                ECO:0000269|PubMed:15024725}.
FT                                /FTId=VAR_060818.
FT   VARIANT     333    333       G -> R (found in a patient with LCA2).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067164.
FT   VARIANT     341    341       L -> S (in RP20; dbSNP:rs61752909).
FT                                {ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_017137.
FT   VARIANT     363    363       P -> T (in LCA2; dbSNP:rs121917744).
FT                                {ECO:0000269|PubMed:10090910,
FT                                ECO:0000269|PubMed:15024725,
FT                                ECO:0000269|PubMed:9326941}.
FT                                /FTId=VAR_017138.
FT   VARIANT     368    368       Y -> C (found in a patient with
FT                                relatively mild LCA2; uncertain
FT                                pathological significance;
FT                                dbSNP:rs62653012).
FT                                {ECO:0000269|PubMed:22509104}.
FT                                /FTId=VAR_070173.
FT   VARIANT     368    368       Y -> H (in RP20; dbSNP:rs62653011).
FT                                {ECO:0000269|PubMed:12960219,
FT                                ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_017139.
FT   VARIANT     393    393       A -> E (in LCA2).
FT                                {ECO:0000269|PubMed:16205573}.
FT                                /FTId=VAR_060819.
FT   VARIANT     393    393       A -> G (in LCA2; dbSNP:rs62635773).
FT                                {ECO:0000269|PubMed:10766140}.
FT                                /FTId=VAR_017140.
FT   VARIANT     417    417       E -> Q (in LCA2; dbSNP:rs62636299).
FT                                {ECO:0000269|PubMed:11462243}.
FT                                /FTId=VAR_017141.
FT   VARIANT     431    431       Y -> C (in LCA2; dbSNP:rs62636300).
FT                                {ECO:0000269|PubMed:14962443}.
FT                                /FTId=VAR_018151.
FT   VARIANT     434    434       A -> V (in LCA2; dbSNP:rs34627040).
FT                                {ECO:0000269|PubMed:10090910,
FT                                ECO:0000269|PubMed:15024725}.
FT                                /FTId=VAR_034477.
FT   VARIANT     435    435       Y -> C (in LCA2; dbSNP:rs62636302).
FT                                {ECO:0000269|PubMed:14611946}.
FT                                /FTId=VAR_060820.
FT   VARIANT     436    436       G -> V (in RP20; dbSNP:rs62637002).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060821.
FT   VARIANT     452    452       V -> G (in RP20; dbSNP:rs62637004).
FT                                {ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_017142.
FT   VARIANT     470    470       P -> L (in LCA2).
FT                                {ECO:0000269|PubMed:17297704}.
FT                                /FTId=VAR_060822.
FT   VARIANT     473    473       V -> D (in RP20; dbSNP:rs62637007).
FT                                {ECO:0000269|PubMed:15024725,
FT                                ECO:0000269|PubMed:16205573,
FT                                ECO:0000269|PubMed:9501220}.
FT                                /FTId=VAR_060823.
FT   VARIANT     477    477       D -> G (probable disease-associated
FT                                mutation found in autosomal dominant
FT                                retinitis pigmentosa with choroidal
FT                                involvement).
FT                                {ECO:0000269|PubMed:21654732}.
FT                                /FTId=VAR_067757.
FT   VARIANT     515    515       R -> W (in RP20; this mutation has been
FT                                found in compound heterozygosity in LCA2;
FT                                dbSNP:rs121917745).
FT                                {ECO:0000269|PubMed:15557452}.
FT                                /FTId=VAR_037619.
FT   VARIANT     528    528       G -> V (in RP20).
FT                                {ECO:0000269|PubMed:11095629}.
FT                                /FTId=VAR_060824.
FT   MUTAGEN     106    106       C->A: Membrane associated.
FT                                {ECO:0000269|PubMed:19049981}.
FT   MUTAGEN     112    112       C->A: Loss of enzymatic activity. No
FT                                palmitoylation. Loss of membrane
FT                                association.
FT                                {ECO:0000269|PubMed:19049981}.
FT   MUTAGEN     180    180       H->A: Loss of enzymatic activity.
FT                                {ECO:0000269|PubMed:16198348}.
FT   MUTAGEN     241    241       H->A: Decreasing protein levels. Loss of
FT                                enzymatic activity. Significantly
FT                                decreased protein stability.
FT                                {ECO:0000269|PubMed:16198348}.
FT   MUTAGEN     313    313       H->A: Decreasing protein levels. Loss of
FT                                enzymatic activity. Significantly
FT                                decreased protein stability.
FT                                {ECO:0000269|PubMed:16198348}.
FT   MUTAGEN     469    469       E->A: Decreasing protein levels. Loss of
FT                                enzymatic activity.
FT                                {ECO:0000269|PubMed:16198348}.
FT   MUTAGEN     469    469       E->Q: Decreasing protein levels. Loss of
FT                                enzymatic activity.
FT                                {ECO:0000269|PubMed:16198348}.
FT   MUTAGEN     527    527       H->A: Decreasing protein levels. Loss of
FT                                enzymatic activity. Significantly
FT                                decreased protein stability.
FT                                {ECO:0000269|PubMed:16198348}.
FT   CONFLICT    254    254       E -> G (in Ref. 3; BAF82614).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       N -> D (in Ref. 3; BAF82614).
FT                                {ECO:0000305}.
SQ   SEQUENCE   533 AA;  60948 MW;  7193C93F3325798D CRC64;
     MSIQVEHPAG GYKKLFETVE ELSSPLTAHV TGRIPLWLTG SLLRCGPGLF EVGSEPFYHL
     FDGQALLHKF DFKEGHVTYH RRFIRTDAYV RAMTEKRIVI TEFGTCAFPD PCKNIFSRFF
     SYFRGVEVTD NALVNVYPVG EDYYACTETN FITKINPETL ETIKQVDLCN YVSVNGATAH
     PHIENDGTVY NIGNCFGKNF SIAYNIVKIP PLQADKEDPI SKSEIVVQFP CSDRFKPSYV
     HSFGLTPNYI VFVETPVKIN LFKFLSSWSL WGANYMDCFE SNETMGVWLH IADKKRKKYL
     NNKYRTSPFN LFHHINTYED NGFLIVDLCC WKGFEFVYNY LYLANLRENW EEVKKNARKA
     PQPEVRRYVL PLNIDKADTG KNLVTLPNTT ATAILCSDET IWLEPEVLFS GPRQAFEFPQ
     INYQKYCGKP YTYAYGLGLN HFVPDRLCKL NVKTKETWVW QEPDSYPSEP IFVSHPDALE
     EDDGVVLSVV VSPGAGQKPA YLLILNAKDL SEVARAEVEI NIPVTFHGLF KKS
//
